Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The compound FR901379, a sulfated echinocandin produced by the filamentous fungus F-11899, is an important intermediate for the synthesis of the antifungal drug micafungin. In this study, we established an efficient clustered regularly interspaced short palindromic repeats/Cas9-based gene editing tool for the industrial production strain SIPI1284. With this method, the efficiency of gene mutagenesis in the target locus is up to 84%, which enables the rapid gene disruption for the analysis of FR901379 biosynthetic genes. Next, we verified the putative functional genes of the FR901379 biosynthetic gene cluster via gene disruption and gene complementation in vivo. These core functional genes included the nonribosomal peptide synthetase gene (), the fatty-acyl-AMP ligase gene () responsible for the formation of the activated form of palmitic acid and its transfer to , four nonheme mononuclear iron oxygenase genes (, , , and ) responsible for the synthesis of nonproteinogenic amino acids, l-homotyrosine biosynthesis genes (), two cytochrome P450 enzyme genes ( and ), and a transcription regulator gene (). In addition, by screening the whole genome, we identified two unknown genes ( and ) responsible for the sulfonyloxy group of FR901379, which were separated from the core FR901379 biosynthetic cluster. Furthermore, during gene disruptions in the research, we obtained a series of FR901379 analogues and elucidated the relationship between the groups and antifungal activities.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acschembio.2c00250DOI Listing

Publication Analysis

Top Keywords

fr901379 biosynthetic
16
gene
10
analysis fr901379
8
genes
8
biosynthetic genes
8
clustered regularly
8
regularly interspaced
8
interspaced short
8
short palindromic
8
palindromic repeats/cas9-based
8

Similar Publications

Article Synopsis
  • Echinocandin B and FR901379 are antifungal lipopeptides used to treat severe fungal infections, with modified fatty acid chains developed to reduce toxicity.
  • A new echinocandin E acylase (ECEA) was discovered from a Mariana Trench sediment sample, which helps to enhance the development of these antifungal compounds.
  • The findings highlight the potential of exploring deep-sea biodiversity for discovering new enzymes that can aid in developing therapeutics.
View Article and Find Full Text PDF

Insight into advances for the biosynthetic progress of fermented echinocandins of antifungals.

Microb Biotechnol

January 2024

Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu, Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, Nanjing, China.

Article Synopsis
  • Invasive fungal infections are on the rise, posing significant health threats, but current antifungal treatments face limitations like drug resistance and side effects.
  • Echinocandins, a promising family of antifungals, are effective against fungi by targeting their cell walls, with three variants (caspofungin, anidulafungin, and micafungin) available for clinical use.
  • To enhance the production of echinocandins and develop new derivatives, understanding their biosynthetic processes, aided by advancements in genome sequencing and gene-editing technology, is crucial.
View Article and Find Full Text PDF

Biosynthesis mechanism, genome mining and artificial construction of echinocandin O-sulfonation.

Metab Eng

November 2022

Shandong Provincial Key Laboratory of Synthetic Biology, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, 266101, China; Key Laboratory of Biofuels, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, 266101,

Micafungin, a semisynthetic derivative of the cyclic hexapeptide FR901379 produced by Coleophoma empetri fermentation, is the only O-sulfonated echinocandin-type antifungal drug. However, the detailed formation mechanism of O-sulfonate group, whether before or after the assembly of hexapeptide, remains elusive. Here, we confirmed that O-sulfonylation occurs after hexapeptide assembly as a kind of postmodification in the biosynthesis of FR901379.

View Article and Find Full Text PDF

Analysis of FR901379 Biosynthetic Genes in by Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Based Genomic Manipulation.

ACS Chem Biol

August 2022

State Key Laboratory of New Drug and Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai Institute of Pharmaceutical Industry, Shanghai 201203, China.

Article Synopsis
  • FR901379 is a sulfated echinocandin produced by the fungus F-11899, serving as a precursor for the antifungal drug micafungin.
  • Researchers developed a highly efficient CRISPR/Cas9 gene editing tool for the industrial strain SIPI1284, achieving 84% efficiency in gene mutagenesis to study FR901379 biosynthetic genes.
  • The study verified key functional genes involved in FR901379 biosynthesis and identified additional genes contributing to its sulfonyloxy group, while also producing several FR901379 analogues to explore their antifungal properties.
View Article and Find Full Text PDF

Micafungin is an important echinocandin antifungal agent for the treatment of invasive fungal infections. In industry, micafungin is derived from the natural product FR901379, which is a non-ribosomal cyclic hexapeptide produced by the filamentous fungus . The difficulty of genetic manipulation in restricts the clarification of FR901379 biosynthetic mechanism.

View Article and Find Full Text PDF